CAS 953778-63-7
:"(R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide "
Description:
The chemical substance known as (R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide, with the CAS number 953778-63-7, is a synthetic organic compound characterized by its complex structure, which includes a cyclopropyl group, a pyridine moiety, and a trifluoroethoxy substituent. This compound is likely to exhibit specific pharmacological properties due to its unique arrangement of functional groups, which may influence its interactions with biological targets. The presence of the trifluoroethoxy group suggests potential lipophilicity, which can affect its solubility and permeability in biological systems. Additionally, the chirality indicated by the (R) configuration may play a crucial role in its biological activity, as enantiomers can exhibit different effects in pharmacological contexts. Overall, this compound may be of interest in medicinal chemistry, particularly in the development of new therapeutic agents, although detailed studies would be necessary to elucidate its specific properties and potential applications.
Formula:C20H21F3N2O2
InChI:InChI=1S/C20H21F3N2O2/c1-13(18-9-8-17(11-24-18)27-12-20(21,22)23)25-19(26)10-14-2-4-15(5-3-14)16-6-7-16/h2-5,8-9,11,13,16H,6-7,10,12H2,1H3,(H,25,26)/t13-/m1/s1
InChI key:GEYDMBNDOVPFJL-CYBMUJFWSA-N
SMILES:C[C@H](C1=NC=C(C=C1)OCC(F)(F)F)NC(=O)CC2=CC=C(C=C2)C3CC3
Synonyms:- (R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamid
- Pregnane X receptor,TTA-A2,neurological diseases,T-type calcium channel,Inhibitor,Ca2+ channels,Ca channels,Electrocorticogram,TTAA2,sleep disorders,TTA-A-2,inhibit,TTA A2,Epilepsy,Calcium Channel
- Benzeneacetamide, 4-cyclopropyl-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]-
- "(R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide "
- TTA-A2
- 2-(4-cyclopropylphenyl)-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
(R)-2-(4-CYCLOPROPYLPHENYL)-N-(1-(5-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-2-YL)ETHYL)ACETAMIDE
CAS:(R)-2-(4-CYCLOPROPYLPHENYL)-N-(1-(5-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-2-YL)ETHYL)ACETAMIDEPurity:97%Molecular weight:378.394989(R)-2-(4-Cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide
CAS:Formula:C20H21F3N2O2Purity:98%Color and Shape:SolidMolecular weight:378.3881TTA-A2
CAS:TTA-A2: T-type calcium channel blocker; anticonvulsant targeting Cav3.1, Cav3.2; IC50 of 89/92 nM; potential for treating neurological conditions.Formula:C20H21F3N2O2Purity:99.5% - 99.9%Color and Shape:SolidMolecular weight:378.3881(R)-2-(4-Cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide
CAS:(R)-2-(4-Cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamideFormula:C20H21F3N2O2Purity:98%Molecular weight:378.39TTA-A2
CAS:TTA-A2 is a t-type calcium channel blocker. It has been shown to reduce locomotor activity and activate lymphatic vessels in rats. TTA-A2 is also a potential drug target for metabolic disorders, such as obesity, diabetes, and hypertension. TTA-A2 has been shown to have anti-inflammatory effects on the bowel that may be due to its ability to inhibit intracellular calcium concentration. Other studies have shown that TTA-A2 can be used for the treatment of bowel disease and inflammatory bowel disease. In addition, there are no side effect profiles associated with TTA-A2.
Formula:C20H21F3N2O2Purity:Min. 95%Molecular weight:378.4 g/mol
